Oxford Biomedica PLC
22 November 2005
BLOCKLISTING SIX MONTHLY RETURN
INFORMATION PROVIDED ON THIS FORM MUST BE TYPED OR PRINTED ELECTRONICALLY.
To: The FSA
Date: 21 November 2005
1. Name of applicant: Oxford Biomedica plc
2. Name of scheme Oxford Biomedica Share Option Scheme
3. Period of return: From 20 May 2005 To 18 November 2005
4. Balance under scheme from
previous return: 11,145,379
5. The amount by which the block
scheme has been increased, if
the scheme has been increased
since the date of the last
return: -
6. Number of securities issued/
allotted under scheme during
period: 2,940,089
7. Balance under scheme not yet
issued / allotted at end of
period 8,205,290
8. Number and class of
securities originally listed 17,383,143 ordinary shares of 1p each on
and the date of admission 9 May 2001
9. Total number of securities in
issue at the end of the period 378,110,169
Name of contact Andrew Wood
Address of contact Oxford Biomedica plc
Medawar Centre
Oxford Science Park
Oxford
OX4 4GA
Telephone number of contact 01865 783 000
Signed by Andrew Wood
Chief Financial Officer, for and on behalf of
Oxford Biomedica plc
Name of applicant
If you knowingly or recklessly give false or misleading information you may be
liable to prosecution.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.